In this large population-based cohort of middle-aged UK men, PSA testing was independently associated with age, a family history of prostate cancer, higher education, living with a wife or partner, private healthcare, height, having had a vasectomy, being diagnosed with cancer or hypertension and consuming a healthy diet. The gene discussed is KLK3; the disease is prostate carcinoma.